Theralogix launches enhanced absorption CBD product certified by NSF International

Theralogix has launched TheraHemp, which is formulated with VESIsorb for enhanced absorption, and independently tested and certified for content accuracy and purity by NSF International.

Theralogix (Rockville, MD) has launched TheraHemp, which is formulated with VESIsorb for enhanced absorption, and independently tested and certified for content accuracy and purity by NSF International. The certification ensures that TheraHemp’s THC content is non-detectable at 100 ppm (0.01%) and contains the exact amount of CBD shown on the label, which is particularly important for people subject to drug testing such as competitive athletes, first responders, and many individuals holding commercial driver’s licenses.

By formulating with VESIsorb, a patented emulsification agent that mimics the body’s natural process of fat digestions, overall absorption of CBD is 300% greater and three times faster. Each TheraHemp softgel is standardized to provide 20 mg of CBD along with 8 mg of beta-caryophyllene-enriched terpenes.